undamentalytics Newsletter
Sign in

Institution

Public Investment Fund

13F for the quarter to June 30, 2026, filed August 14, 2026 · SEC CIK 1767640

Reported value
$37.9bn
87% in companies we cover
Positions we cover
4
Largest SPCX 69.5%
Copy, a year
+8.0%
S&P 500 +15.6%
Copy Sharpe ratio
0.31
S&P 500 0.72

How copying its 13F would have done

$10.0k$20.0k 20192020202120222023202420252026 $30.6k$18.1k
CopyS&P 500 $10,000 copying Public Investment Fund's filed holdings in companies we cover from February 15, 2019, buying on the first trading day after each 13F was filed and holding until the next, against the S&P 500 (total return). Marked weekly, log scale. Before costs and taxes; misses trading within each quarter and anything 13F does not show (shorts, cash, bonds, non-US holdings).

Biggest drop −47.7% (S&P 500 −31.8%); beta 1.34; alpha −5.9% a year (t = −0.59); last 12 months −31.6% against +12.1%.

Reported value by quarter

Public Investment Fund: 13F reported value Total value of all positions in each quarter's 13F, as filed (values before 2023 were filed in thousands of dollars and are converted).
$0 $10T $20T $30T $40T Reported value, 2018-12-31: $2.8B Reported value, 2019-03-31: $2.3B Reported value, 2019-06-30: $5.2B Reported value, 2019-09-30: $4.2B Reported value, 2019-12-31: $2.2B Reported value, 2020-03-31: $9.8B Reported value, 2020-06-30: $10.1B Reported value, 2020-09-30: $7B Reported value, 2020-12-31: $12.8B Reported value, 2021-03-31: $15.4B Reported value, 2021-06-30: $15.9B Reported value, 2021-09-30: $43.4B Reported value, 2021-12-31: $55.9B Reported value, 2022-03-31: $43.9B Reported value, 2022-06-30: $41.1B Reported value, 2022-09-30: $36.8B Reported value, 2022-12-31: $30.9T Reported value, 2023-03-31: $35.5B Reported value, 2023-06-30: $38.9B Reported value, 2023-09-30: $36.5B Reported value, 2023-12-31: $35.2B Reported value, 2024-03-31: $18B Reported value, 2024-06-30: $17.5B Reported value, 2024-09-30: $19.5B Reported value, 2024-12-31: $19.2B Reported value, 2025-03-31: $19.5B Reported value, 2025-06-30: $18.1B Reported value, 2025-09-30: $19.4B Reported value, 2025-12-31: $12.9B Reported value, 2026-03-31: $12B Reported value, 2026-06-30: $37.9B 2018-12-31 2020-06-30 2021-12-31 2023-06-30 2024-12-31 2026-06-30 $37.9B
View chart data
Period Reported value
2018-12-31 $2.8B
2019-03-31 $2.3B
2019-06-30 $5.2B
2019-09-30 $4.2B
2019-12-31 $2.2B
2020-03-31 $9.8B
2020-06-30 $10.1B
2020-09-30 $7B
2020-12-31 $12.8B
2021-03-31 $15.4B
2021-06-30 $15.9B
2021-09-30 $43.4B
2021-12-31 $55.9B
2022-03-31 $43.9B
2022-06-30 $41.1B
2022-09-30 $36.8B
2022-12-31 $30.9T
2023-03-31 $35.5B
2023-06-30 $38.9B
2023-09-30 $36.5B
2023-12-31 $35.2B
2024-03-31 $18B
2024-06-30 $17.5B
2024-09-30 $19.5B
2024-12-31 $19.2B
2025-03-31 $19.5B
2025-06-30 $18.1B
2025-09-30 $19.4B
2025-12-31 $12.9B
2026-03-31 $12B
2026-06-30 $37.9B

Holdings and moves

CompanyShare of portfolioValueSharesChange in shares
SPCXSpace Exploration Technologies Corp69.48%$26.3bn154.15MNew
UBERUber13.87%$5.3bn72.84M0.0%
LCIDLucid Group, Inc.3.13%$1.2bn177.09M0.0%
CTEVClaritev Corp0.12%$43.7m1.28M0.0%
CompanyBought (value)Shares
SPCXSpace Exploration Technologies Corp$26.3bn154.15M

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

None this quarter.

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

No positions in covered companies were sold out this quarter.

  • Industrials96.4%
  • Consumer Discretionary3.6%

Share of the value held in companies we cover, by sector.

PeriodCopy, a yearS&P 500SharpeS&P 500Biggest dropBeta
Whole backtestFebruary 15, 2019 to November 2, 2026+8.0%+15.6%0.310.72−47.7%1.34
Last three yearsNovember 3, 2023 to November 2, 2026+8.2%+21.8%0.261.16−37.6%1.05
Last yearNovember 7, 2025 to November 2, 2026−28.1%+14.2%−1.070.84−34.8%0.87

From SEC Form 13F data sets. A 13F lists long positions in US-listed shares at the quarter's end, filed up to 45 days later; it does not show shorts, cash, bonds, non-US holdings or trades within the quarter. Positions in companies outside our coverage are not listed here. Research, not investment advice.